F
4D Molecular Therapeutics, Inc.
FDMT · NASDAQ · Healthcare · 637M
Price · close
$15.83
-1.68% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.8×
Enterprise value / EBITDAEV/EBITDA
-6.6×
Free cash flow yieldFCF yield
-11.9%
Return on equityROE
-27.7%
Operating margin
-187.2%
Net debt / EBITDAbalance-sheet strength
0.3×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.